Stryker Corporation Cash Flow Statement
SYK / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Stryker Corporation generated $5.0B in operating cash flow and $4.3B in free cash flow in FY2025. Free cash flow margin was 73.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $654.0M | $3.0B | $2.0B | $1.6B | $2.0B | $3.6B | $1.0B | $1.6B | $1.4B | $515.0M | $1.4B | $515.0M | $1.0B | $1.3B | $1.1B |
| Depreciation & Amortization | $1.6B | $1.4B | $1.3B | $1.1B | $1.3B | $966.0M | $859.0M | $752.0M | $590.0M | $586.0M | $590.0M | $586.0M | $511.0M | $410.0M | $385.0M |
| Operating Cash Flow | $5.0B | $4.2B | $3.3B | $3.3B | $3.3B | $2.6B | $1.6B | $1.9B | $981.0M | $1.8B | $981.0M | $1.8B | $1.9B | $1.5B | $1.5B |
| Capital Expenditures | $761.0M | $755.0M | $525.0M | $487.0M | $525.0M | $572.0M | $598.0M | $490.0M | $270.0M | $233.0M | $270.0M | $233.0M | $195.0M | $182.0M | $131.0M |
| Free Cash Flow | $4.3B | $3.5B | $2.7B | $2.8B | $2.7B | $2.0B | $961.0M | $1.4B | $711.0M | $1.5B | $711.0M | $1.5B | $1.7B | $1.4B | $1.3B |
| Share Buybacks | - | - | - | - | $0 | $300.0M | $230.0M | $13.0M | $700.0M | $100.0M | $700.0M | $100.0M | $317.0M | $426.0M | $426.0M |
| Dividends Paid | $1.3B | $1.2B | $950.0M | $863.0M | $950.0M | $703.0M | $636.0M | $568.0M | $521.0M | $462.0M | $521.0M | $462.0M | $401.0M | $238.0M | $198.0M |
| FCF Margin | 73.0% | 15.4% | 16.0% | 19.4% | 16.0% | 15.0% | 7.7% | 12.6% | 7.1% | 16.0% | 7.1% | 16.0% | 18.8% | 18.6% | 19.8% |